What is Drug-Resistant Tuberculosis?
Drug-Resistant TB occurs when bacteria become resistant to the drugs used to treat TB. This means that the drug can no longer kill the TB bacteria.
Multidrug-resistant TB (MDR TB) is a type of DR-TB where TB bacteria is resistant to both Isoniazid and Rifampicin, the two most potent anti-TB drugs.
Health Volunteers are often the regular point of contact for a TB patient in the community. They support the TB patient during the entire episode of TB and ensure complete diagnosis and treatment.
What is Drug-Resistant Tuberculosis?
What is Drug-Sensitive Tuberculosis(DS-TB)
The World Health Organisation End TB Strategy, adopted by the World Health Assembly in 2014, aims to end the global TB epidemic. The strategy draws on the opportunities presented by the Sustainable Development Goals (SDGs), especially those goals aimed at achieving universal health coverage and social protection from disease.
The table given below provides information on the vision, goal, milestones and targets for the End TB Strategy.
The Senior Treatment Supervisor (STS) interacts with the patient care ecosystem from the time a TB case is notified, diagnosed and anti-TB treatment is initiated.
The key interactions include:
need to interact with Patient, Health Volunteers, Treatment Supporters, Field staff (CHO, MPHW, ANM), LT, MO, MO-TC , DTO, DR-TB coordinator, STLS, and pharmacist at PHI level, TU and DDS; With Nikshay, Nikshay Aushadhi,
Explain what is TB care ecosystem
The Epidemiologic Triad is a model used in the field of epidemiology to study diseases and how they are spread. It consists of a triangle with three vertices or corners.
The three vertices for infectious diseases consist of:
1. Agent, or microbe that is the factor causing the disease.
2. Host, or organism harbouring the disease.
3. Environment, or those external factors that cause or allow disease transmission.